NCT04147806View on ClinicalTrials.gov

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

July 13, 2026

Study Completion Date

July 13, 2026

Conditions
Prostate Cancer
Interventions
RADIATION

IGRT 45 Gy in 5 fractions of 9 Gy

Administration of 9 Gy in five consecutive days, to a total dose of 45 Gy radiation

RADIATION

IGRT 24 Gy single dose

Administration of a single dose of 24 Gy in one session

DRUG

Dexamethasone

4 mg by mouth on treatment days only

DRUG

Tamsulosin

0.4 mg by mouth daily starting the day of simulation and until 2 weeks post-treatment.

Trial Locations (1)

10467-2490

Montefiore Medical Center - Moses Campus, The Bronx

All Listed Sponsors
lead

Albert Einstein College of Medicine

OTHER